294 related articles for article (PubMed ID: 8769190)
1. Comparison of Neoral and Sandimmune preparations in renal transplant patients--improved pharmacokinetics with neoral.
Warrens AN; Salama A; Waters JB; Lechler RI
Transplant Proc; 1996 Aug; 28(4):2169-70. PubMed ID: 8769190
[No Abstract] [Full Text] [Related]
2. Conversion from conventional Sandimmun to Neoral therapy in stable renal transplant recipients.
Løkkegaard H; Asmundsson P; Clausen P; Dieperink H; Hansen JM; Heaf J; Jensen SB; Kornerup HJ; Madsen S; Pedersen EB; Poulsen JV; Rasmussen K
Transplant Proc; 1996 Aug; 28(4):2199-201. PubMed ID: 8769199
[No Abstract] [Full Text] [Related]
3. Use of Neoral in pediatric renal transplantation.
Ettenger RE; Smith HT; Kaiser B; Cooney GF; Summerauer J; Alexander S; Moulton LT; Choc MG; Wong RL
Transplant Proc; 1996 Aug; 28(4):2257-8. PubMed ID: 8769217
[No Abstract] [Full Text] [Related]
4. Cyclosporine pharmacokinetics in renal allograft recipients with diabetes mellitus with Sandimmune and Sandimmune Neoral.
Serafinowicz A; Gaciong Z; Baçzkowska T; Durlik M; Lao M
Transplant Proc; 1996 Dec; 28(6):3140-1. PubMed ID: 8962217
[No Abstract] [Full Text] [Related]
5. Cyclosporine neoral pharmacokinetics in kidney and heart transplant patients.
Schiavelli R; Sgrosso JL; Sabbatiello R; Castro C; Ahualli L; Pattin M; Vazquez MC
Transplant Proc; 1996 Dec; 28(6):3343-4. PubMed ID: 8962299
[No Abstract] [Full Text] [Related]
6. Pharmacokinetic analysis of Neoral conversion in pediatric and adult renal transplant recipients with poor absorption of Sandimmune.
Pescovitz MD; Henson S; Bodziak K; Book BK; Gonin J; Jindal RM; Leapman SB; Milgrom ML; Filo RS
Transplant Proc; 1996 Aug; 28(4):2165-8. PubMed ID: 8769189
[No Abstract] [Full Text] [Related]
7. Case studies: conversion from Sandimmune to Neoral in stable renal allograft recipients.
Roth D; Miller J
Transplant Proc; 1996 Aug; 28(4):2219-20; discussion 2218. PubMed ID: 8769204
[No Abstract] [Full Text] [Related]
8. Conversion from Sandimmune to Neoral in stable renal and pancreas transplant recipients enhances cyclosporine absorption.
Chapman JR; O'Connell PJ; Bovington KJ; Allen RD
Transplant Proc; 1996 Aug; 28(4):2293-5. PubMed ID: 8769229
[No Abstract] [Full Text] [Related]
9. Limited sampling strategy to estimate exposure to cyclosporine A in renal allograft recipients treated with Sandimmune-Neoral.
Serafinowicz A; Gaciong Z; Baçzkowska T; Rell K; Lao M; Wałaszewski J
Transplant Proc; 1996 Dec; 28(6):3138-9. PubMed ID: 8962216
[No Abstract] [Full Text] [Related]
10. Conversion from Sandimmune to Neoral and induction therapy with Neoral in pediatric renal transplant recipients.
Hoyer PF; Boekenkamp A; Vester U; Offner G; Brodehl J
Transplant Proc; 1996 Aug; 28(4):2259-61. PubMed ID: 8769218
[No Abstract] [Full Text] [Related]
11. Case study: de novo application of Neoral in renal transplantation.
Kahan BD
Transplant Proc; 1996 Aug; 28(4):2189-91; discussion 2192, 2195. PubMed ID: 8769196
[No Abstract] [Full Text] [Related]
12. Oral cyclosporine preparations immediately following renal transplantation.
Katz SM; Amante A; Schoenberg L; Kahan BD
Transplant Proc; 1996 Aug; 28(4):2164. PubMed ID: 8769188
[TBL] [Abstract][Full Text] [Related]
13. Transfer of patients with kidney grafts to Sandimmun Neoral normalizes the calcium level in erythrocyts.
Babarykin D; Amerika D; Adamsone I; Valinietse M; Rosental R
Transplant Proc; 1996 Dec; 28(6):3137. PubMed ID: 8962215
[No Abstract] [Full Text] [Related]
14. Neoral pharmacokinetics in cynomolgus monkeys: relation to efficacy in renal allografting.
Schuurman HJ; Hengy JC; Ringers J; Vonderscher J; Schuler W; Jonker M
Transplant Proc; 1996 Dec; 28(6):3142-4. PubMed ID: 8962218
[No Abstract] [Full Text] [Related]
15. Cyclosporine pharmacokinetics in stable renal transplant patients: effect of formulation Sandimmun versus Consupren versus Neoral.
Masri MA; Barbari A; Stephan A; Kamel G; Frem G; Younan F; Rizk S; Moubarak R; Karam A
Transplant Proc; 1996 Jun; 28(3):1318-20. PubMed ID: 8658676
[No Abstract] [Full Text] [Related]
16. Conversion from Sandimmune to Neoral in stable liver graft recipients.
Pollard SG; Lodge JP
Transplant Proc; 1996 Aug; 28(4):2244-6. PubMed ID: 8769213
[No Abstract] [Full Text] [Related]
17. Conversion from cyclosporine to Neoral in pediatric recipients for kidney, liver, and heart transplantation.
Holmberg C; Laine J; Jalanko H; Leijala M; Hoppu K
Transplant Proc; 1996 Aug; 28(4):2262-3. PubMed ID: 8769219
[No Abstract] [Full Text] [Related]
18. Role of postdose cyclosporine monitoring in living renal transplant recipients.
Thomas R; Minz M; Singh B; Heer M; Kashyap R
Transplant Proc; 2004 Sep; 36(7):2104. PubMed ID: 15518761
[TBL] [Abstract][Full Text] [Related]
19. Use of cyclosporine microemulsion (Neoral) in de novo and stable renal transplantation: clinical impact, pharmacokinetic consequences and economic benefits. Canadian and International Neoral Study Groups.
Keown PA
Transplant Proc; 1996 Aug; 28(4):2147-50. PubMed ID: 8769183
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the long-term tolerability, pharmacodynamics, and safety of Sandimmune and Neoral in liver transplant recipients. Ontario Liver Transplant Study Group.
Grant D; Rochon J; Levy G
Transplant Proc; 1996 Aug; 28(4):2232-3. PubMed ID: 8769208
[No Abstract] [Full Text] [Related]
[Next] [New Search]
